BofA Securities Upgrades Ovintiv(OVV.US) to Buy Rating, Announces Target Price $43
Ovintiv Price Target Cut to $53.00/Share From $59.00 by Barclays
Ovintiv Is Maintained at Overweight by Barclays
Barclays Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $53
Wells Fargo Maintains Ovintiv(OVV.US) With Hold Rating, Raises Target Price to $46
Ovintiv Is Maintained at Equal-Weight by Wells Fargo
Ovintiv Analyst Ratings
TD Cowen Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $57
Goldman Sachs Maintains Ovintiv(OVV.US) With Hold Rating, Cuts Target Price to $47
Morgan Stanley Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $50
Morgan Stanley Remains a Buy on Ovintiv (OVV)
Scotiabank Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $48
CIBC Maintains Ovintiv(OVV.US) With Hold Rating, Cuts Target Price to $48
RBC Capital Maintains Ovintiv(OVV.US) With Hold Rating, Maintains Target Price $55
Ovintiv (OVV) Receives a Hold From RBC Capital
UBS Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $43
BMO Capital Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $55
Barclays Maintains Ovintiv(OVV.US) With Buy Rating, Maintains Target Price $59
Barclays Remains a Buy on Ovintiv (OVV)
Evercore Maintains Ovintiv(OVV.US) With Buy Rating, Cuts Target Price to $54